Lion Bioscience has signed Akzo-Nobel subsidiary Intervet International as a pre-launch customer for its everEST software for EST clustering analysis.
Intervet, a Netherlands-based animal health company, also licensed genomeScout, Lion’s genome analysis software, and extended its existing licenses for the SRS data integration platform and bioScout genomic annotation system for an additional three years.
Financial terms of the agreement were not disclosed.
Intervet is the second company to license and implement everEST. Lion has also installed the software, which it will officially launch in the second quarter of the year, at Nestle.
EverEST is based on Lion’s SRS platform and combines data retrieval with EST clustering.
“For the first time, the user can retrieve biological information concerning ESTs and EST consensus sequences from all major biological databases,” said Christian Marcazzo, Lion’s director of product marketing.
“Built-in applications can be launched to further analyze consensus sequences, such as Blast or Lion’s annotation application bioScout,” Marcazzo said.
EST clustering is performed with the built-in StackPack clustering engine, which Lion non-exclusively licensed last fall from Electric Genetics in South Africa. StackPack includes data management and visualization tools that enable researchers to rapidly cluster, align, and analyze high volumes of ESTs and partial-length sequences. These tools highlight variations in transcripts and can accelerate gene discovery, gene function analysis, expression analysis, and drug development.
Andrea Kreisselmeier, director of marketing and communications at Lion, said that everEST “complements our life science informatics offering in order to achieve a comprehensive IT solution covering the entire R&D process of the life science industry.”
Kreisselmeier said that that the data integration capability provided by the SRS platform is unique for EST clustering software, and gives everEST the edge over Lion’s competitors.
— BT and MMJ